18-9102714-G-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS1

The NM_021074.5(NDUFV2):​c.-30G>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000384 in 1,572,884 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 1 hom. )

Consequence

NDUFV2
NM_021074.5 5_prime_UTR_premature_start_codon_gain

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -1.23
Variant links:
Genes affected
NDUFV2 (HGNC:7717): (NADH:ubiquinone oxidoreductase core subunit V2) The NADH-ubiquinone oxidoreductase complex (complex I) of the mitochondrial respiratory chain catalyzes the transfer of electrons from NADH to ubiquinone, and consists of at least 43 subunits. The complex is located in the inner mitochondrial membrane. This gene encodes the 24 kDa subunit of complex I, and is involved in electron transfer. Mutations in this gene are implicated in Parkinson's disease, bipolar disorder, schizophrenia, and have been found in one case of early onset hypertrophic cardiomyopathy and encephalopathy. A non-transcribed pseudogene of this locus is found on chromosome 19. [provided by RefSeq, Oct 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 18-9102714-G-T is Benign according to our data. Variant chr18-9102714-G-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 327875.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Benign=1}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00205 (312/152364) while in subpopulation AFR AF = 0.0069 (287/41594). AF 95% confidence interval is 0.00624. There are 1 homozygotes in GnomAd4. There are 154 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFV2NM_021074.5 linkc.-30G>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 8 ENST00000318388.11 NP_066552.2 P19404
NDUFV2NM_021074.5 linkc.-30G>T 5_prime_UTR_variant Exon 1 of 8 ENST00000318388.11 NP_066552.2 P19404
NDUFV2XR_243808.4 linkn.16G>T non_coding_transcript_exon_variant Exon 1 of 8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFV2ENST00000318388.11 linkc.-30G>T 5_prime_UTR_premature_start_codon_gain_variant Exon 1 of 8 1 NM_021074.5 ENSP00000327268.6 P19404
NDUFV2ENST00000318388.11 linkc.-30G>T 5_prime_UTR_variant Exon 1 of 8 1 NM_021074.5 ENSP00000327268.6 P19404

Frequencies

GnomAD3 genomes
AF:
0.00204
AC:
310
AN:
152246
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00687
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.000400
AC:
73
AN:
182636
AF XY:
0.000321
show subpopulations
Gnomad AFR exome
AF:
0.00716
Gnomad AMR exome
AF:
0.000288
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000257
Gnomad OTH exome
AF:
0.000211
GnomAD4 exome
AF:
0.000206
AC:
292
AN:
1420520
Hom.:
1
Cov.:
30
AF XY:
0.000179
AC XY:
126
AN XY:
703560
show subpopulations
African (AFR)
AF:
0.00783
AC:
245
AN:
31272
American (AMR)
AF:
0.000358
AC:
14
AN:
39074
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25196
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36846
South Asian (SAS)
AF:
0.0000247
AC:
2
AN:
80932
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49580
Middle Eastern (MID)
AF:
0.000435
AC:
2
AN:
4596
European-Non Finnish (NFE)
AF:
0.00000274
AC:
3
AN:
1094292
Other (OTH)
AF:
0.000443
AC:
26
AN:
58732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
14
29
43
58
72
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00205
AC:
312
AN:
152364
Hom.:
1
Cov.:
32
AF XY:
0.00207
AC XY:
154
AN XY:
74512
show subpopulations
African (AFR)
AF:
0.00690
AC:
287
AN:
41594
American (AMR)
AF:
0.00124
AC:
19
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68030
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
19
38
57
76
95
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000556
Hom.:
2
Bravo
AF:
0.00243

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mitochondrial complex I deficiency, nuclear type 1 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
5.9
DANN
Benign
0.78
PhyloP100
-1.2
PromoterAI
0.0047
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Mutation Taster
=298/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139650842; hg19: chr18-9102712; API